Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Arthritis gene therapy's first death.

    Evans CH, Ghivizzani SC, Robbins PD.

    Arthritis Res Ther. 2008;10(3):110. Epub 2008 May 27.

    PMID:
    18510784
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    In memoriam: tougher rules could be the legacy of gene therapy's first death.

    Boyce N.

    New Sci. 1999 Dec 18;164(2217):9. No abstract available.

    PMID:
    11902198
    [PubMed - indexed for MEDLINE]
    3.

    Gene therapy's trials.

    [No authors listed]

    Nature. 2000 Jun 8;405(6787):599. No abstract available.

    PMID:
    10864286
    [PubMed - indexed for MEDLINE]
    4.

    Joint efforts: tackling arthritis using gene therapy. First International Meeting on the Gene Therapy of Arthritis and Related Disorders. Bethesda, MD, USA, 2-3 December 1998.

    Evans CH, Rediske JJ, Abramson SB, Robbins PD.

    Mol Med Today. 1999 Apr;5(4):148-51. No abstract available.

    PMID:
    10203745
    [PubMed - indexed for MEDLINE]
    5.

    Death but one unintended consequence of gene-therapy trial.

    Sibbald B.

    CMAJ. 2001 May 29;164(11):1612. No abstract available.

    PMID:
    11402803
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Researchers and regulators reflect on first gene therapy death.

    Hollon T.

    Nat Med. 2000 Jan;6(1):6. No abstract available.

    PMID:
    10613797
    [PubMed - indexed for MEDLINE]
    7.

    Gene therapy's new era: a balance of unequivocal benefit and unequivocal harm.

    Friedmann T.

    Mol Ther. 2003 Jul;8(1):5-7. No abstract available.

    PMID:
    12872762
    [PubMed - indexed for MEDLINE]
    8.

    Clinical trials. Gene transfer an unlikely contributor to patient's death.

    Kaiser J.

    Science. 2007 Dec 7;318(5856):1535. No abstract available.

    PMID:
    18063761
    [PubMed - indexed for MEDLINE]
    9.

    Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

    Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

    J Rheumatol. 2010 Apr;37(4):692-703. Epub 2009 Dec 23.

    PMID:
    20032102
    [PubMed - indexed for MEDLINE]
    10.

    Clinical research. Death prompts a review of gene therapy vector.

    Kaiser J.

    Science. 2007 Aug 3;317(5838):580. No abstract available.

    PMID:
    17673625
    [PubMed - indexed for MEDLINE]
    11.

    The FDA's proposal for public disclosure of adverse events in gene therapy trials.

    Barnbaum DR.

    Politics Life Sci. 2000 Sep;19(2):261-8.

    PMID:
    15468489
    [PubMed - indexed for MEDLINE]
    12.

    Gene therapy setback.

    Beardsley T.

    Sci Am. 2000 Feb;282(2):36-7. No abstract available.

    PMID:
    10710784
    [PubMed - indexed for MEDLINE]
    13.

    Human gene therapy: science under fire.

    SoRelle R.

    Circulation. 2000 Mar 28;101(12):E9023-4. No abstract available.

    PMID:
    10736304
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Death in gene therapy trial raises questions about private IRBs.

    Ledford H.

    Nat Biotechnol. 2007 Oct;25(10):1067. No abstract available.

    PMID:
    17921976
    [PubMed - indexed for MEDLINE]
    15.

    Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency.

    Wilson JM.

    Mol Genet Metab. 2009 Apr;96(4):151-7. Epub 2009 Feb 10.

    PMID:
    19211285
    [PubMed - indexed for MEDLINE]
    16.

    Studies illuminate cause of fatal reaction in gene-therapy trial.

    Stephenson J.

    JAMA. 2001 May 23-30;285(20):2570. No abstract available.

    PMID:
    11368717
    [PubMed - indexed for MEDLINE]
    17.

    Gene therapy institute denies that errors led to trial death.

    Smaglik P.

    Nature. 2000 Feb 24;403(6772):820. No abstract available.

    PMID:
    10733385
    [PubMed - indexed for MEDLINE]
    18.

    INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

    [No authors listed]

    Drugs R D. 2007;8(3):176-87. Review.

    PMID:
    17472413
    [PubMed - indexed for MEDLINE]
    19.

    Gene therapy's web of corporate connections.

    Marshall E.

    Science. 2000 May 12;288(5468):954-5. No abstract available.

    PMID:
    10841712
    [PubMed - indexed for MEDLINE]
    20.

    Tribulations of a trial.

    Wenner M.

    Sci Am. 2009 Sep;301(3):14-5. No abstract available.

    PMID:
    19708513
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk